pancreatic cancer

News

Data Published in Annals of Surgery Conclude Irreversible Electroporation Utilizing NanoKnife Results in Substantially Prolonged Survival for Patients With Locally Advanced Pancreatic Cancer Compared With Historical Controls

08/13/2015

ALBANY, N.Y., Aug. 13, 2015 (GLOBE NEWSWIRE) -- AngioDynamics, a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, announced today the publication of...

ALBANY, N.Y., Aug. 13, 2015...

08/13/2015

IO Learning

News

Targeted, High-Dose Stereotactic Body Radiation Therapy Appears to Benefit Some Patients With Pancreatic Cancer

05/20/2015

Two non-randomized studies were conducted in relatively small numbers of patientsReleased: 18-May-2015 1:40 PM EDT Newswise — Two studies from Johns Hopkins Kimmel Cancer Center researchers add to preliminary evidence that high-dose...

Two non-randomized studies were...

05/20/2015

IO Learning

Clinical Insights

Pancreatic Irreversible Electroporation: An Alternative to Pancreatic Metastasectomy?

04/01/2015

Shree R. Venkat, MD; Govindarajan Narayanan, MD

Shree R. Venkat, MD; Govindarajan Nar...

Abstract: In the presence of metastatic disease, the 5-year overall survival drops from 74% to approximately 8% in patients with renal cell carcinoma. Solitary metastases to the pancreas are uncommon, as disease is more often found in the...

Abstract: In the presence of...

04/01/2015

IO Learning

Interview

The Interventional Oncology Calendar for 2014

02/19/2014

ASCO GI concluded in San Francisco with several highlights and included the first randomized study to show improved overall survival for patients with metastatic pancreas cancer treated with immunotherapy. This was a phase II clinical trial...

ASCO GI concluded in San...

02/19/2014

IO Learning